Search Results
Results found for "Structure Therapeutics"
- Ep 61 with About Dr. Marta Filizola
The overall goal of her research program is to obtain rigorous mechanistic insights into the structure To this end, her lab uses several computational structural biology tools and rational drug design approaches
- Removing the GPCR-mediated brake on exocytosis enhances insulin action, promotes adipocyte browning, and protects against diet-induced obesity
GPCR signal transduction and neuroscience, and she has expanded it in the areas of drug discovery and structural Her research focuses on the structure and function of GTP binding proteins and the molecular mechanisms studying G protein coupled signal transduction for many years and has made key discoveries in G protein structure
- Ep 147 with Dr. Demet Araç
Axel Brunger’s lab at Stanford University to study the structure and function of cell-adhesion proteins journey of studying adhesion GPCRs, the challenges he faced, and the progress made in understanding their structure adhesion GPCRs, outlining his collaborations, challenges, and the progress made in understanding their structure collaborations and improved their understanding of the GPCRs through various approaches, including structural the field has seen significant growth, with important discoveries such as the transmembrane region structures
- Ep 18 with Dr. Yamina Berchiche
The explosion of biomedical data such as in genomics, structural biology, and pharmacology can provide How can we best leverage these exciting new techniques in areas such as protein structure prediction,
- Ep 13 with Dr. Amynah Pradhan
Andrew Charles that who specialized in animal models of migraine and delta-opioid receptors as a therapeutic
- Illuminating Functional Selectivity and Allosterism at GPCRs.
He is also an Associate Leader of the Experimental Therapeutics and Metabolism Program and the Director
- Ep 157 with Dr. Nagarajan Vaidehi
She has advanced the use of computational methods to meet the challenges of designing therapeutics with
- Ep 167 with Drs. Tom Sakmar & Ilana Kotliar
This could accelerate discovery of therapeutic targets by combining multiplex data with focused downstream As the field advances, the computational layer — including AlphaFold and structural prediction tools
- Yamina's Corner | Dr. GPCR Ecosystem
Clear Platform Assessment: Gain rapid, independent insight into GPCR platform risks and true therapeutic Operational Discipline I instill structure and consistency across every phase of your discovery process
- Ep 35 with Dr. Brian Arey
His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics
- Ep 34 with Dr. Brian Arey
His recently published book on signaling bias, Biased Signaling in Physiology, Pharmacology, and Therapeutics
- Ep 80 with Dr. Andrew Tobin
vehicle by which Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics
- Targeting adenosine signaling for immuno-oncology
clinical stage company developing next generation immunotherapies, and member of the SAB of Domain Therapeutics
- Ep 31 with Dr. Kevin Pfleger
Institute of Medical Research, Deputy Director of the Australian Research Council Centre for Personalised Therapeutics
- Ep 56 with Dr. Adriano Marchese
The ultimate goal of Adriano’s research is to target novel aspects of GPCR signaling for therapeutic
- Ep 70 with Dr. Stephen Ferguson
Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).
- Distinct sub-cellular signal propagation as a component of functional selectivity
of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics
- Weekly News October 16 | Dr. GPCR Ecosystem
Eric Trinquet —how structured play turns into assays and why serendipity belongs in your build process
- Ep 69 with Dr. Stephen Ferguson
Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).
- GPCR Retreat 2023 - Part I
protein-coupled receptors (GPCRs) regulate motivated behavior and how these receptors can be targeted for therapeutic distinct signaling pathways with their physiological effects and may serve as the basis for more selective therapeutics
- Ep 146 with Dr Michael Feigin
Michael Feigin is an Associate Professor in the Department of Pharmacology and Therapeutics, and Director of Graduate Studies of Experimental Therapeutics at Roswell Park Comprehensive Cancer Center in Buffalo disrupting histone processing on rapidly proliferating cells, such as cancer cells, and suggested a therapeutic
- Ep 163 with Dr. Dmitry Veprintsev
Membrane Proteins and Receptors (COMPARE), University of Nottingham, where he provides leadership in structural group leader at the Paul Scherrer Institute and ETH Zürich in Switzerland, changing his attention to structural
- Weekly News October 23 | Dr. GPCR Ecosystem
Jens Carlsson on predictive modeling—where structure-based design and MD guide experiments (and where
- Ep 23 with Dr. Qing Fan
Qing is a structural biologist interested in the molecular mechanisms controlling how class C GPCRs transmit
- Trainee Symposium II
My primary research focus lies in gaining deeper insights into the structural mechanisms governing G lab for her postdoc in 2018 where she has employed protein engineering, receptor pharmacology, and structural
- Biotech Growth | Dr. GPCR Ecosystem
guides program momentum Focus resources where they’ll change outcomes No More Strategy Swirl I build structure up clear deliverables across internal and CRO teams Keep cross-functional teams moving with shared structure
- Ep 113 with Dr. Prasenjit Saha
receptors would be a significant breakthrough in cardiovascular biology as they could be targeted for therapeutic
- Ep 50 with Dr. Thomas P. Sakmar
Tom initially focused on structure-activity relationships underlying spectral tuning and identified a micro-domains” and the “helix movement model of receptor activation” were confirmed later when crystal structures
- Ep 165 with Chuck DeWeese & Joe St. Germain
Chuck stepped in to help structure the nonprofit’s financial framework , showcasing how specialized knowledge It's about structure, order, and breakthrough moments , not unlike the life of a researcher. Accounting for Grants: Buckets, Structure & Strategy The discussion covers the unique complexities of
- Foundry for GPCR Organizations | Dr. GPCR Ecosystem
Stay competitive with structured, science-driven upskilling. → Dr. Eliminate trial-and-error with structured growth frameworks.


























